February 20, 2023
Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients With COVID-19
A Randomized Clinical Trial: https://jamanetwork.com/journals/jama/fullarticle/2801827
In http://tribeqr.com/v/gatessubstack the key traits for looking at any study to see if it is designed to fail
a) Look at the Authors and look for the Author Affiliations with the Bill and Melinda Gates Foundation (BMGF)
Review Authors and Contributors to see affiliations
The Excel File will help:
Here is a template form from the New England Journal of Medicine that Authors of this paper must fill out in disclosing conflicts of interests:
Excerpt:
Ticks this box and exposes what might be called a Vipers Nest:
The following affiliates who have received Grants from BMGF were identified.
Grants Identified so far to these affiliates:
Duke University $327,737,456.00 - Lead Author(s)
University of Virginia $77,972,045.00
University of Minnesota $30,106,045.00
Vanderbilt University $21,772,416.00
Cornell University parent University of Weill Cornell Medicine $252,673,940.00
Johns Hopkins University $1,000,711,384.00
Foundation for the National Institutes of Health (FNIH) $507,728,384.00
University of Pittsburgh $62,084,198.00
University of Colorado $36,651,234.00
University of Florida $22,411,438.00
b) Look at the Method; There you will invariably see one or more obvious design flaws from i),ii),iii) and iv) Identified and tested below:
i) Not done in the early stages (eg after Viral replication has taken place)
Ticks this box; See the study : Results
By the time this study was done it was common knowledge that Ivermectin, when used in the prevention and or treatment of Covid19 is used as part of multi-drug Protocols and is MOST effective when treated in the first 5 days of the disease.
See: https://aapsonline.org/covidpatientguide/ available for well over a year
This is the stage when Covid19 is in the viral replication phase
In a trial designed to fail for Ivermectin it would insure Ivermectin was not given in the first 5 days.
In this trial:
“Study staff verified eligibility criteria including age of 30 years or older, SARS-CoV-2 infection within 10 days (positive polymerase chain reaction or antigen test result, including home-based tests)”
and
" Exclusion criteria included hospitalization, ivermectin use within 14 days”
In this trial the mean time between giving the limited 6 days course in this study was FIVE (5) days with 40% not receiving the drug within this time
ii) Wrong and/or known dangerous dosages
Ticks this Box See the Study : Introduction
"ivermectin (600 μg/kg daily for 6 days)"
By the time this study was done it was common knowledge that Ivermectin, when used in the prevention and or treatment of Covid19 is used as part of multi-drug Protocols and is MOST effective when used for 5 to 30 days of the disease.
See: https://aapsonline.org/covidpatientguide/
In a trial designed to fail for Ivermectin it would insure Ivermectin was not given for a long enough period
iii) In the absence of known critical partner Drugs - in the case of HCQ and Ivermectin without Zinc
Ticks this Box See the Study : Methods Sub Section Interventions
It has been known for years now that Ivermectin is a Zinc Ionophore and that this property alone can account for the LIFE SAVING results being seen around the globe in clinics using BOTH Zinc and Ivermectin in their Covid-19 treatment Protocols
This paper way back in 2010 showed this path was (or should have been) common knowledge. You and no doubt the Authors of this “study” can and could have seen it in the October 2010 Paper!!
It is worth repeating: at the time of this study it was academic and medical common knowledge that Ivermectin and Hydroxychloroquine were being used as Zinc Ionophores in LIFE SAVING Covid-19 treatments. and this study omitted Zinc!
See: https://pubmed.ncbi.nlm.nih.gov/21079686/
You can also directly download it here; some of the “respected” medical journals are now removing peer reviewed and accepted papers that their sponsors may not like published.
Download
This “study” clearly Ticks this “Failure Design” Box
See: https://aapsonline.org/covidpatientguide/
iv) Done on a population group where you can expect a good outcome regardless of what was tested hence "no statistical difference" result
Common Trick 1) - Low Risk Age Group - Most participants under the age of 75
Common Trick 2) - Small Study Population - Under 100
Ticks this Box for age See the Results : Study Population
The median (IQR) age of the participants was 48 (38-58) years
which uncovers that 75% of the participants were under 58
(IQR) Means the middle 50% of participants in that age range (Namely 38-58)
So a further 25% of the study group are under 38 Years of Age
The chances of Hospitalization because of Covid19 are very low
By the time this study was done it was common knowledge that the hospitalization and death with Covid19 was highly age related because the elderly do not have as strong an immune system as the majority of the population. Median ages of Death “with Covid” was known to be circa 80 years old and above.
From the CDC Website
In a trial designed to fail for Ivermectin it would insure Ivermectin was not given to a large group of the most at risk candidates. Giving an intervention to the least at risk individuals; those with a natural immune system best equipped to deal with an infection will significantly if not completely mask observable differences from the intervention which is reported world wide to reduce hospitalization and death for those at most risk.
If this trial had limited the age of participants to 65 and above they would have been able to observe possible differences of outcomes that were orders of magnitude greater than was possible with the the age group criteria of this study.
Put simply, proposing a trial designed like this one was like saying “we will limit the study to people that we would ordinarily expect to recover without an intervention (young people) and see if the intervention makes any difference.
To read up more on the “The War On Ivermectin” :
Direct link https://www.amazon.com/exec/obidos/ASIN/151077386X
Share link you can text : http://tribeqr.com/v/gatesivermectin02
For Another Study Designed to fail see: http://tribeqr.com/v/gatesivermectin01
For yet Another Study Designed to fail see: http://tribeqr.com/v/gatesivermectin03
Twitter Share Link: https://twitter.com/tniwef/status/1659555857624084480
Disclaimer: All content is presented for educational and/or entertainment purposes only. Under no circumstances should it be mistaken for professional advice, nor is it at all intended to be taken as such. The contents simply reflect current newsworthy items on Covid that are freely available. It is subject to error and change without notice. The presence of a link to a website does not indicate approval or endorsement of that web site or any services, products, or opinions that may be offered by them.
Neither this Substack nor any of its principals or contributors are under any obligation to update or keep current the information contained herein.
Although the information contained is derived from sources which are believed to be reliable, they cannot be guaranteed.
Disclosure: We accept no advertising or compensation, and have no material connection to any products, brands, topics or companies mentioned anywhere on this post.
Fair Use Notice: This post may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. This post is making such material available in efforts to advance understanding of issues of social significance. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit. If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.
Ivermectin 02 : Another Sponsored Study With a Design That Will Fail.